The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
After a top producer warned the world’s uranium production may start to slip, the price of the radioactive material started to soar.
The toast of the early 2000s, many prominent news and lifestyle sites like Vice and Buzzfeed have fallen on hard times.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Boomers are ahead of younger generations in embracing from the Chinese e-commerce marketplace.
The retailer questioned how the proposed deal would be financed, but it may just be delaying the inevitable.
In the wake of monthslong work stoppages by both writers and actors, musicians prepare to negotiate over similar issues.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Many of the medicines are the most popular in the sector, including popular weight loss drugs Ozempic and Mounjaro.
The budget airline’s fate is uncertain after a court ruled that its merger with JetBlue would harm consumers.
The filing adds to its ever-growing health tech capabilities — and its growing mountain of data to keep safe.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.